A STUDY OF CLINICAL SPECTRUM, RISK FACTORS AND OUTCOME OF DRUG-INDUCED MOVEMENT DISORDERS
Objective: We aimed to characterize the spectrum of DIMDs, and the culprit agents commonly encountered in the movement disorder clinic. We also set out to…Novel Antipsychotics and Risk of Drug-Induced Movement Disorders and Tardive Syndromes
Objective: To review evidence on the risk of drug-induced movement disorders (DIMDs) with newer antipsychotic (AP) drugs. Background: DIMDs, both acute/subacute “extrapyramidal symptoms” and chronic…The association between antipsychotic-induced akathisia and suicidality: a systematic review
Objective: This systematic review aims to establish whether a causal association exists between antipsychotic-induced akathisia and suicidality, in order to guide further clinical decision making…Levosulpiride Induced Movement Disorder: 7 cases
Objective: Through this article we want to highlight extrapyramidal side effects of levosulpiride and need of its awareness among treating physicians. Background: Levosulpiride is a…Risk of movement disorders with antipsychotic drugs in patients with schizophrenia or depressive disorders
Objective: To compare the risk of movement disorders with antipsychotic drugs (APDs) in patients suffering from Schizophrenia or Depressive Disorders. Background: APDs are well-known causes…A survey of movement disorders in a large sample of patients treated with antipsychotic medication
Objective: To describe the prevalence and nature of movement disorders (MD) in a large sample of patients treated with antipsychotic medication. Background: Although there are…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.